Highlights and Quick Summary
- Annual Free Cash Flow Margin for 2022 was -15.32% (a -385.82% decrease from previous year)
- Annual Free Cash Flow Margin for 2021 was 5.36% (a -78.9% decrease from previous year)
- Annual Free Cash Flow Margin for 2020 was 25.4% (a 177.9% increase from previous year)
- Twelve month Free Cash Flow Margin ending June 30, 2023 was -33.41% (a 16.98% increase compared to previous quarter)
- Twelve month trailing Free Cash Flow Margin decreased by -899.28% year-over-year
Trailing Free Cash Flow Margin for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -33.41% | -28.56% | -13.37% | 4.18% |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Margin of Emergent Biosolutions Inc.
Most recent Free Cash Flow Marginof EBS including historical data for past 10 years.Interactive Chart of Free Cash Flow Margin of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Free Cash Flow Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -15.32% |
| 2021 | – | – | – | – | 5.36% |
| 2020 | – | – | – | – | 25.4% |
| 2019 | – | – | – | – | 9.14% |
| 2018 | – | – | – | – | -3.54% |
| 2017 | – | – | – | – | 27.33% |
| 2016 | – | – | – | – | -4.42% |
| 2015 | – | – | – | – | -0.47% |
| 2014 | – | – | – | – | 20.19% |
| 2013 | – | – | – | – | 17.57% |
| 2012 | – | – | – | – | -0.86% |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic